文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

凝血功能障碍在脓毒性休克患者血小板减少相关死亡中的作用

[Role of coagulation dysfunction in thrombocytopenia-related death in patients with septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论脓毒性休克患者血小板减少是死亡的独立危险因素(OR=3.338),其中51%的血小板减少相关死亡可能归因于凝血功能异常。

本研究为回顾性病例对照研究,纳入北京大学人民医院EICU和ICU于2015年4月1日至2023年1月31日收治的301例脓毒性休克患者,按入ICU后24小时内最低血小板计数是否<100×10⁹/L分为血小板减少组(172例,57.1%)和非血小板减少组(129例,42.9%),主要结局为ICU住院期间死亡。多因素Logistic回归显示血小板减少(OR=3.338,95%CI 1.910-5.834,P=0.000)、连续性肾脏替代治疗(OR=3.175,95%CI 1.576-6.395,P=0.001)和凝血酶原时间(OR=1.077,95%CI 1.011-1.147,P=0.021)是脓毒性休克患者住院死亡的独立危险因素。中介分析显示,脓毒性休克患者血小板减少导致的死亡中51%归因于凝血功能障碍。提示凝血功能异常在血小板减少相关死亡中起重要作用。

要点

  • 脓毒性休克患者入ICU后24小时内最低血小板计数<100×10⁹/L者占57.1%(172/301),是住院死亡的独立危险因素(OR=3.338,95%CI 1.910-5.834,P=0.000)。
  • 连续性肾脏替代治疗(OR=3.175,95%CI 1.576-6.395,P=0.001)和凝血酶原时间延长(OR=1.077,95%CI 1.011-1.147,P=0.021)也是脓毒性休克患者住院死亡的独立危险因素。
  • 中介分析显示,脓毒性休克患者血小板减少导致的死亡中51%归因于凝血功能障碍。
  • 单因素分析中,血小板减少(OR=4.478)、连续性肾脏替代治疗(OR=4.601)、弥散性血管内凝血(OR=6.248)、血清肌酐(OR=1.005)、尿素氮(OR=1.126)、总胆红素(OR=1.006)和凝血酶原时间(OR=1.126)均为住院死亡的危险因素(均P<0.05)。

适用人群与场景

  • 2015年4月1日至2023年1月31日北京大学人民医院急诊重症监护病房(EICU)和重症监护病房(ICU)收治的脓毒性休克患者。

诊断标准与关键阈值

  • 以入ICU后24小时内最低血小板计数<100×10⁹/L定义为血小板减少。
  • 结局指标为ICU住院期间死亡。

研究设计与关键结果

  • 研究类型为回顾性病例对照研究,共纳入301例脓毒性休克患者,其中血小板减少组172例(57.1%),非血小板减少组129例(42.9%)。
  • 两组在年龄、死亡率、弥散性血管内凝血(DIC)、连续性肾脏替代治疗以及肌酐、尿素氮、总胆红素、白细胞计数、淋巴细胞计数、凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)水平方面差异有统计学意义。
  • 单因素Logistic回归分析显示,血小板减少(OR=4.478)、连续性肾脏替代治疗(OR=4.601)、DIC(OR=6.248)、血清肌酐(OR=1.005)、尿素氮(OR=1.126)、总胆红素(OR=1.006)和PT(OR=1.126)是脓毒性休克患者住院死亡的危险因素(均P<0.05)。
  • 多因素Logistic回归分析显示,血小板减少(OR=3.338,95%CI 1.910-5.834,P=0.000)、连续性肾脏替代治疗(OR=3.175,95%CI 1.576-6.395,P=0.001)和PT(OR=1.077,95%CI 1.011-1.147,P=0.021)是脓毒性休克患者住院死亡的独立危险因素。
  • 中介分析显示,脓毒性休克患者血小板减少导致的死亡中51%归因于凝血功能障碍。

证据类型、等级与局限

  • 证据类型:回顾性病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血小板减少是脓毒性休克患者死亡的强预测因子,血小板减少相关死亡中约一半可能归因于凝血功能异常。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the effect of thrombocytopenia on the prognosis of patients with septic shock and its mechanism in leading to death.

METHODS: A retrospective case-control study was conducted. Patients with septic shock admitted to emergency intensive care unit (EICU) and intensive care unit (ICU) in Peking University People's Hospital from April 1, 2015 to January 31, 2023 were enrolled. Patients were divided into the thrombocytopenia group and the non-thrombocytopenia group, according to whether the minimum platelet count was less than 100×109/L within 24 hours after admission to ICU. The outcome index was the mortality during ICU stay. The baseline data, hospitalization information and laboratory test results of the two groups were compared, and the risk factors of in-hospital death were analyzed by Logistic regression, and the mediation effect was performed by Bootstrap method.

RESULTS: A total of 301 patients with septic shock were enrolled, of which 172 (57.1%) had thrombocytopenia and 129 (42.9%) did not. There were significant differences between the two groups in age, mortality, disseminated intravascular coagulation (DIC), continuous renal replacement therapy, and level of creatinine, urea nitrogen, total bilirubin, white blood cell count, lymphocyte count, prothrombin time (PT) and activated partial thromboplastin time (APTT). Univariate Logistic regression analysis showed thrombocytopenia [odds ratio (OR) = 4.478], continuous renal replacement therapy (OR = 4.601), DIC (OR = 6.248), serum creatinine (OR = 1.005), urea nitrogen (OR = 1.126), total bilirubin (OR = 1.006) and PT (OR = 1.126) were risk factors of death during hospitalization in patients with septic shock (all P < 0.05). Multivariate Logistic regression analysis showed that thrombocytopenia [OR = 3.338, 95% confidence interval (95%CI) was 1.910-5.834, P = 0.000], continuous renal replacement therapy (OR = 3.175, 95%CI was 1.576-6.395, P = 0.001) and PT (OR = 1.077, 95%CI was 1.011-1.147, P = 0.021) were independent risk factors for in-hospital mortality in patients with septic shock. Mediation analysis showed that 51% of the deaths due to thrombocytopenia in patients with septic shock were due to coagulopathy.

CONCLUSIONS: Thrombocytopenia is a powerful predictor of death in septic shock patients, and half of all thrombocytopenia-related deaths may be due to abnormal coagulation function.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang G, Sun C, Hao C, et al. [Role of coagulation dysfunction in thrombocytopenia-related death in patients with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 38149383. doi:10.3760/cma.j.cn121430-20230729-00563

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。